Viz.ai Launches AI-Powered Vascular Imaging Software
The artificial intelligence (AI)-enabled Viz™ Vascular Suite reportedly allows automated detection of vascular conditions, shown on computed tomography (CT) and other imaging modalities, and facilitates timely triage among interdisciplinary teams.
An emerging artificial intelligence (AI) software, which can be utilized with multiple imaging modalities, may enhance the assessment and timely care coordination for vascular conditions, including aortic dissection and pulmonary embolism.
The recently launched Viz Vascular Suite can be utilized with a variety of imaging modalities, including computed tomography (CT) and echocardiography, to provide automated analysis of suspected vascular conditions, according to the software’s manufacturer Viz.ai.
After a vascular condition has been identified, Viz.ai said the Viz Vascular Suite software app sends alerts and patient imaging scans via HIPAA-compliant means to the mobile devices of providers. Philip Batista, M.D., emphasized the ability of the Viz Vascular Suite to foster timely notification and interdisciplinary care for patients with serious vascular conditions.
“When Viz identifies an abnormal scan, it quickly notifies the appropriate specialists regardless of their location, facilitating seamless communication via mobile application,” noted Dr. Batista, an assistant professor of surgery and associate program director of Vascular and Endovascular Surgery Residency at the Cooper Medical School of Rowan University in Camden, N.J. “We’ve been using the Viz software for the last several months and have seen improvements in patient care across our institution.”
(Editor’s note: For related articles, see “AI-Powered Algorithm May Enhance CT Assessment of Aortic Dissection,” “Pie Medical Imaging Launches AI-Powered Echocardiography Platform” and “FDA Clears AI-Powered Echocardiography Platform for Detecting Heart Failure with Preserved Ejection Fraction.”)
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Twenty Years of CT Colonography for Colorectal Cancer Screening: What the Research Reveals
August 2nd 2025Computed tomography colonography (CTC) demonstrated a 91.6 percent positive predictive value (PPV) for polyps > 6 mm, according to new research involving over 9,000 patients who underwent CTC for primary asymptomatic colorectal cancer screening.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
August 2nd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.
Study Reveals Significant Prevalence of Abnormal PET/MRI and Dual-Energy CT Findings with Long Covid
August 2nd 2025In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.
